Int Arch Allergy Immunol:毛茸动物敏感以及与屋尘螨诱导的过敏性鼻炎临床相关性

2020-06-17 AlexYang MedSci原创

毛茸动物过敏原对屋尘螨(HDM)诱导的过敏性鼻炎(AR)的影响仍不清楚。最近,有研究人员调查了毛茸动物过敏原的共敏感和交叉敏感以及与HDM诱导的AR之间的临床相关性。

毛茸动物过敏原对屋尘螨(HDM)诱导的过敏性鼻炎(AR)的影响仍不清楚。最近,有研究人员调查了毛茸动物过敏原的共敏感和交叉敏感以及与HDM诱导的AR之间的临床相关性。

研究包括了268名HDM诱导的AR患者,且对狗和/或猫过敏原皮刺测试为阳性。研究发现,AR和哮喘(AS;n=166),轻度到中度永久性AR(n=132)和e1P-e2P(n=89)组的VAS评分均比单一AR(n=102)、其他AR分类和其他敏感情况更高。组分的lgE阳性率,比如Can f 1-3和Fel d 2以及大鼠、绵羊、小鼠、牛和马的组分在e1P-e2P组患者中最高。Can f 1-4、Fel d 1、Fel d 2或者其他联合过敏原与VAS评分呈现正相关关系。AR和AS,对Can f 4、Fel d 1和小鼠敏感均是VAS评分不小于5的HDM诱导AR患者的风险因子。

最后,研究人员指出,他们在Can f1 -3、Fel d2、或大鼠、绵羊、小鼠、牛和马提取物中发现了大量的交叉敏感和共敏感。更高水平的Can f1 -4和Fel d 1-2 slgE水平或者更多的毛茸动物过敏原数量将会导致更加严重的症状并减少生活质量。结合AS,对Can f 4和Fel d 1以及小鼠敏感均是中度到重度HDM诱导AR的风险因子。

原始出处:

Hao Chen , Zhifeng Huang , Wenting Luo et al. Sensitization to Furry Animals and Clinical Relevance of House Dust Mite-Induced Allergic Rhinitis in Guangzhou, China. Int Arch Allergy Immunol. 09 Jun 2020.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1837847, encodeId=bdbf183e84748, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Jul 25 10:47:25 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047270, encodeId=a2c0204e270fd, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Mar 05 19:47:25 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329384, encodeId=05721329384e0, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Jun 19 04:47:25 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348595, encodeId=c8171348595c4, content=<a href='/topic/show?id=54c24e71237' target=_blank style='color:#2F92EE;'>#屋尘螨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47712, encryptionId=54c24e71237, topicName=屋尘螨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 19 04:47:25 CST 2020, time=2020-06-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1837847, encodeId=bdbf183e84748, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Jul 25 10:47:25 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047270, encodeId=a2c0204e270fd, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Mar 05 19:47:25 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329384, encodeId=05721329384e0, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Jun 19 04:47:25 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348595, encodeId=c8171348595c4, content=<a href='/topic/show?id=54c24e71237' target=_blank style='color:#2F92EE;'>#屋尘螨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47712, encryptionId=54c24e71237, topicName=屋尘螨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 19 04:47:25 CST 2020, time=2020-06-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1837847, encodeId=bdbf183e84748, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Jul 25 10:47:25 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047270, encodeId=a2c0204e270fd, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Mar 05 19:47:25 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329384, encodeId=05721329384e0, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Jun 19 04:47:25 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348595, encodeId=c8171348595c4, content=<a href='/topic/show?id=54c24e71237' target=_blank style='color:#2F92EE;'>#屋尘螨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47712, encryptionId=54c24e71237, topicName=屋尘螨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 19 04:47:25 CST 2020, time=2020-06-19, status=1, ipAttribution=)]
    2020-06-19 膀胱癌
  4. [GetPortalCommentsPageByObjectIdResponse(id=1837847, encodeId=bdbf183e84748, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Jul 25 10:47:25 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047270, encodeId=a2c0204e270fd, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Mar 05 19:47:25 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329384, encodeId=05721329384e0, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Jun 19 04:47:25 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348595, encodeId=c8171348595c4, content=<a href='/topic/show?id=54c24e71237' target=_blank style='color:#2F92EE;'>#屋尘螨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47712, encryptionId=54c24e71237, topicName=屋尘螨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 19 04:47:25 CST 2020, time=2020-06-19, status=1, ipAttribution=)]

相关资讯

Am J Otolaryngol:60岁到75岁过敏性鼻炎患者中舌下免疫治疗效果和依从性分析

最近,有研究人员评估了舌下免疫治疗(SLIT)在不小于60岁的屋尘螨(HDM)诱导的过敏性鼻炎患者中的效果和依从性情况。

Indoor Air:对长途汽车工作人员进行过敏性鼻炎风险预测的诺模图构建

最近,有研究人员调查了室内空气污染物和对过敏性鼻炎健康的影响情况。

Int Forum Allergy Rhinol:慢性鼻炎中鼻后神经冷冻消融术后鼻漏预测因子研究

鼻后神经(PNN)冷冻消融在改善过敏性和非过敏性(NAR)引起的鼻漏方面很有前景。早期的案例表明能够改善75%-80%的患者症状,但是预测PNN冷冻消融成功的预测因子还未有研究。最近,有研究人员评估了

Innate Immun:IL-33/ST2能够促进鼻粘膜上皮细胞的炎症响应

过敏性鼻炎(AR)是一种由环境过敏原介导的鼻黏膜炎症性疾病。目前,IL-33/ST2、ERK1/2途径与AR进展之间的关系需要进一步探索。

Nutrients:呼吸道过敏儿童饮食习惯研究

过敏性疾病增加的趋势与肥胖增加的趋势平行,表明了可能存在相关性。最近,有研究人员就评估了饮食习惯于过敏之间的关系。

Immun Inflamm Dis:舌下免疫治疗后鼻拭子中异染性细胞数量减少

过敏性鼻炎中,过敏原特异性舌下免疫治疗(SLIT)能够减少鼻症状。而SLIT对柳杉花粉病治疗效果的机制仍旧不清楚。最近,有研究人员调查了SLIT治疗柳杉花粉病后异染细胞、嗜酸性粒细胞和中性粒细胞的变化